Cognitive judgment bias in the psychostimulant-induced model of mania in rats

Psychopharmacology

Volumn 232, Issue 3, 2015, Pages 651-660

  Rygula, Rafal ^a   Szczech, Ewa ^a   Kregiel, Jakub ^a   Golebiowska, Joanna ^a   Kubik, Jakub ^a   Popik, Piotr ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Ambiguous cue; Amphetamine; Animal model; Behavioral; Bipolar disorder; Cocaine; Cognitive judgment bias; Mania; Rat

Indexed keywords

COCAINE; DEXAMPHETAMINE; PSYCHOSTIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; COGNITIVE BIAS; CONTROLLED STUDY; DISCRIMINATION LEARNING; EXPERIMENTAL BEHAVIORAL TEST; LONG TERM EXPOSURE; MALE; MANIA; NONHUMAN; OPERANT BEHAVIORAL TEST; RAT; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; BIPOLAR DISORDER; CHEMICALLY INDUCED; DECISION MAKING; DISEASE MODEL; DRUG EFFECTS; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; COCAINE; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; JUDGMENT; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84921628473     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3707-y     Document Type: Article

References (55)

1. Adida M, Maurel M, Kaladjian A, Fakra E, Lazerges P, Da Fonseca D, Belzeaux R, Cermolacce M, Azorin JM (2011). [Decision-making and schizophrenia]. Encephale 37 Suppl 2, S110-116.
2. Adler LE, Rose G, Freedman R (1986) Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 21:787-798
3. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73:133-146
4. Antelman SM, Caggiula AR, Kucinski BJ, Fowler H, Gershon S, Edwards DJ, Austin MC, Stiller R, Kiss S, Kocan D (1998) The effects of lithium on a potential cycling model of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 22:495-510
5. Beck AT, Weishaar ME (1995) Cognitive therapy. In: Corsini RJ, Wedding D (eds) Current psychotherapies, 5th edn. Peacock, Itasca, IL, p 229-261.
6. Belmaker RH, Bersudsky Y (2004) Bipolar disorder: mania and depression. Discov Med 4:239-245
7. Boutros NN, Uretsky N, Berntson G, Bornstein R (1994) Effects of cocaine on sensory inhibition in rats: preliminary data. Biol Psychiatry 36:242-248
8. Boutros NN, Uretsky NJ, Lui JJ, Millana RB (1997) Effects of repeated cocaine administration on sensory inhibition in rats: preliminary data. Biol Psychiatry 41:461-466
9. Carver CS, Johnson SL (2009) Tendencies toward mania and tendencies toward depression have distinct motivational, affective, and cognitive correlates. Cogn Ther Res 33:552-569
10. Enkel T, Gholizadeh D, von Bohlen Und Halbach O, Sanchis-Segura C, Hurlemann R, Spanagel R, Gass P, Vollmayr B (2010) Ambiguous-cue interpretation is biased under stress- and depression-like states in rats. Neuropsychopharmacology 35:1008-1015
11. Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ, Quevedo J, Kapczinski F (2006a) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281-286
12. Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Reus GZ, Hatch JP, Quevedo J, Kapczinski F (2006b) Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol 17:311-318
13. Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F (2006c) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8:275-280
14. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006d) Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res 31:699-703
15. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006e) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-332
16. Gambill JD, Kornetsky C (1976) Effects of chronic d-amphetamine on social behavior of the rat: implications for an animal model of paranoid schizophrenia. Psychopharmacology (Berl) 50:215-223
17. Gamma A, Angst J, Ajdacic-Gross V, Rossler W (2008) Are hypomanics the happier normals? J Affect Disord 111:235-243
18. Giovanelli A, Hoerger M, Johnson SL, Gruber J (2013) Impulsive responses to positive mood and reward are related to mania risk. Cogn Emot 27:1091-1104
19. Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA (1992) Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology (Berl) 107:425-430
20. Harding EJ, Paul ES, Mendl M (2004) Animal behaviour: cognitive bias and affective state. Nature 427:312
21. Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257-262
22. Howell DC (1997) Statistical methods for psychology, 4th edn. Wadsworth, Belmont
23. Johnson SL (2005) Mania and dysregulation in goal pursuit: a review. Clin Psychol Rev 25:241-262
24. Johnson SL, Jones S (2009) Cognitive correlates of mania risk: are responses to success, positive moods, and manic symptoms distinct or overlapping? J Clin Psychol 65:891-905
25. Judd LL, Akiskal HS (2003) The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 73:123-131
26. Kato T, Kubota M, Kasahara T (2007) Animal models of bipolar disorder. Neurosci Biobehav Rev 31:832-842
27. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:617-627
28. Leahy RL (1999) Decision making and mania. J Cogn Psychother 13:83-105
29. Melega WP, Quintana J, Raleigh MJ, Stout DB, Yu DC, Lin KP, Huang SC, Phelps ME (1996) 6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 22:63-69
30. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry 64:543-552
31. Meyendorff E, Lerer B, Moore NC, Bow J, Gershon S (1985) Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment. Psychiatry Res 16:303-308
32. Papciak J, Popik P, Fuchs E, Rygula R (2013) Chronic psychosocial stress makes rats more 'pessimistic' in the ambiguous-cue interpretation paradigm. Behav Brain Res 256:305-310
33. Peet M, Peters S (1995) Drug-induced mania. Drug Saf 12:146-153
34. Ricaurte GA, McCann UD (1992) Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann N Y Acad Sci 648:371-382
35. Ricaurte GA, Mechan AO, Yuan J, Hatzidimitriou G, Xie T, Mayne AH, McCann UD (2005) Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. J Pharmacol Exp Ther 315:91-98
36. Rygula R, Pluta H, Popik P (2012) Laughing rats are optimistic. PLoS One 7:e51959
37. Rygula R, Papciak J, Popik P (2013) Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology 38:2188-2196
38. Rygula, R., Papciak, J., Popik, P. (2014). The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Eur Neuropsychopharmacol 24(7): 1103-1111.
39. Salamy A, Salfi M, Fein G (1997) Sensory gating deficit following cocaine exposure in the rat. Neuropsychobiology 36:83-86
40. Schaffer A, Cairney J, Cheung A, Veldhuizen S, Levitt A (2006) Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics. Can J Psychiatry 51:9-16
41. Seiden LS, Fischman MW, Schuster CR (1976) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215-219
42. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639-677
43. Sharot T, Guitart-Masip M, Korn CW, Chowdhury R, Dolan RJ (2012) How dopamine enhances an optimism bias in humans. Curr Biol 22:1477-1481
44. Solomon PR, Crider A, Winkelman JW, Turi A, Kamer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 16:519-537
45. Stevens KE, Fuller LL, Rose GM (1991) Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res 555:91-98
46. Tenn CC, Fletcher PJ, Kapur S (2003) Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64:103-114
47. van Enkhuizen J, Geyer MA, Kooistra K, Young JW (2013a) Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. Int J Neuropsychopharmacol 16:1021-1031
48. van Enkhuizen J, Geyer MA, Young JW (2013b) Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology (Berl) 225:661-674
49. Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB, Ravert HT, Musachio J, McCann UD, Ricaurte GA (1998) Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18:419-427
50. Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology (Berl) 83:194-199
51. Weiner I, Tarrasch R, Bernasconi E, Broersen LM, Ruttimann TC, Feldon J (1997) Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. Pharmacol Biochem Behav 56:817-826
52. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996a) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703
53. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ (1996b) Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40:428-439
54. Young JW, Henry BL, Geyer MA (2011a) Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol 164:1263-1284
55. Young JW, van Enkhuizen J, Winstanley CA, Geyer MA (2011b) Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. J Psychopharmacol 25:934-943